Palisade Bio (PALI) Non-Current Assets (2010 - 2026)
Palisade Bio's (PALI) quarterly Non-Current Assets came in at $72000.0 in Q1 2026, down 76.24% year-on-year from $303000.0 in Q1 2025, and down 41.46% on a QoQ basis from $123000.0 in Q4 2025.
Palisade Bio (PALI) Non-Current Assets (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Non-Current Assets data on file, last reported at $72000.0 in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 76.24% year-over-year to $72000.0 in Q1 2026; TTM through Mar 2026 was $560000.0, a 67.33% decrease from a year earlier, with the FY2025 full-year figure at $123000.0, down 68.13% from the prior year.
- Non-Current Assets for Q1 2026 stood at $72000.0, down from $123000.0 in the prior quarter.
- Over the last five years, Non-Current Assets for PALI reached as high as $1.1 million in Q3 2022 and fell as low as $72000.0 in Q1 2026.
- Historically, Non-Current Assets has averaged $523000.0 across 5 years, with a median of $466000.0 in 2024.
- Across the five-year window, Non-Current Assets jumped 935.87% in 2023 and plunged 76.24% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $1.0 million in 2022, then dropped by 29.71% to $724000.0 in 2023, then sank by 46.69% to $386000.0 in 2024, then sank by 68.13% to $123000.0 in 2025, then sank by 41.46% to $72000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $72000.0 in Q1 2026, $123000.0 in Q4 2025, and $145000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 220,000.00 |
| Mar 31, 2025 | 303,000.00 |
| Dec 31, 2024 | 386,000.00 |
| Sep 30, 2024 | 466,000.00 |
| Jun 30, 2024 | 559,000.00 |
| Mar 31, 2024 | 639,000.00 |
| Dec 31, 2023 | 724,000.00 |
| Sep 30, 2023 | 801,000.00 |
| Jun 30, 2023 | 879,000.00 |
| Mar 31, 2023 | 953,000.00 |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 391,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 182,000.00 |
| Jun 30, 2021 | 224,000.00 |